INCY Competitors & Rivals

Compare Incyte Corp with top Biotechnology companies

Incyte Corp

INCY - Health Care

Market Cap

$20.2B

Price

$101.27

P/E Ratio

15.80

Revenue Growth

0.3%

View Details

Top Competitors

Apple Inc

AAPL

$264.55

Market Cap

N/A

P/E Ratio

33.85

Rev Growth

6.4%

Microsoft Corp

MSFT

$397.23

Market Cap

N/A

P/E Ratio

36.30

Rev Growth

14.9%

Alphabet Inc

GOOGL

$315.20

Market Cap

N/A

P/E Ratio

28.58

Rev Growth

15.1%

Amazon Com Inc

AMZN

$210.00

Market Cap

$2254.3B

P/E Ratio

29.33

Rev Growth

0.1%

Side-by-Side Comparison

MetricINCYAAPLMSFTGOOGL
Price$101.27$264.55$397.23$315.20
Market Cap$20.2BN/AN/AN/A
P/E Ratio15.8033.8536.3028.58
Revenue Growth0.3%6.4%14.9%15.1%
Profit Margin0.3%0.3%0.4%0.3%

Detailed Head-to-Head Comparisons

Get in-depth analysis comparing INCY with each competitor

Frequently Asked Questions

Who are INCY's main competitors?

INCY's main competitors include AAPL, MSFT, GOOGL, and other companies in the Biotechnology industry. These companies compete directly with Incyte Corp for market share and customers.

How does INCY compare to its competitors?

INCY can be compared to competitors using metrics like market capitalization, P/E ratio, revenue growth, profit margins, and market share. Each competitor has different strengths - some may have better valuations while others have higher growth rates.

What are the best alternatives to INCY stock?

The best alternatives to INCY depend on your investment goals. For similar market exposure, consider AAPL or MSFT. For different risk profiles, research companies with varying market caps and growth trajectories in the Biotechnology sector.

Which is better: INCY or AAPL?

Comparing INCY vs AAPL requires analyzing valuation metrics, growth prospects, competitive advantages, and risk factors. Neither is universally "better" - the right choice depends on your investment strategy, risk tolerance, and market outlook.

What makes INCY different from its competitors?

Incyte Corp differentiates itself through its unique business model, product offerings, market positioning, and competitive advantages. Factors like brand strength, innovation, operational efficiency, and financial health distinguish INCY from rivals.

Should I diversify across INCY and its competitors?

Diversifying across multiple companies in the same industry can reduce company-specific risk while maintaining sector exposure. However, this doesn't eliminate sector risk. Consider diversifying across different industries and sectors for better risk-adjusted returns.

Continue Your Research

Explore more analysis tools for INCY

Explore Categories